Previous studies have shown the oncogenic role of FOXD1 in glioma [12], non-small cell lung cancer [13], and breast cancer [14] etc. FOXD1 has not been extensively studied, especially in HNSC. This evidence concerns the gene FOXD1 and central nervous system cancer.